Search for the advancement of the International Journal of Clinical Oncology (IJCO) Kazue Ozawa Editorial 04 December 2014 Pages: 1 - 2
Cancer registration system: an introduction Tomotaka Sobue Introduction to Review Articles 11 November 2014 Pages: 3 - 4
Cancer registries in Japan: National Clinical Database and site-specific cancer registries Takayuki AnazawaHiroaki MiyataMitsukazu Gotoh Review Article 08 November 2014 Pages: 5 - 10
Recent trends in population-based cancer registries in Japan: the Act on Promotion of Cancer Registries and drastic changes in the historical registry Tomohiro MatsudaTomotaka Sobue Review Article 30 October 2014 Pages: 11 - 20
Hypofractionated chemoradiotherapy with temozolomide as a treatment option for glioblastoma patients with poor prognostic features Yu Jin LimIl Han KimTae Min Kim Original Article 05 April 2014 Pages: 21 - 28
Prognostic impact of completion of initial high-dose methotrexate therapy on primary central nervous system lymphoma: a single institution experience Keishi MakinoHideo NakamuraJun-ichi Kuratsu Original Article 11 April 2014 Pages: 29 - 34
Clinicopathological significance of androgen receptor, HER2, Ki-67 and EGFR expressions in salivary duct carcinoma Tatsuo MasubuchiYuichiro TadaToshitaka Nagao Original Article 20 February 2014 Pages: 35 - 44
Radiotherapy for thoracic tumors: association between subclinical interstitial lung disease and fatal radiation pneumonitis Shinsaku YamaguchiTakayuki OhguriYukunori Korogi Original Article 11 March 2014 Pages: 45 - 52
Stereotactic body radiation therapy for primary lung cancers clinically diagnosed without pathological confirmation: a single-institution experience Tadamasa YoshitakeKatsumasa NakamuraHiroshi Honda Original Article 08 May 2014 Pages: 53 - 58
The impact of a fourteen-gene molecular assay on physician treatment decisions in non-small-cell lung cancer Shane DormadyMichael S. BroderThierry Jahan Original Article 06 June 2014 Pages: 59 - 69
Do the derived neutrophil to lymphocyte ratio and the neutrophil to lymphocyte ratio predict prognosis in breast cancer? Ahmet DiricanBetul Bolat KucukzeybekMustafa Oktay Tarhan Original Article 18 February 2014 Pages: 70 - 81
Perception and needs of reproductive specialists with regard to fertility preservation of young breast cancer patients Chikako ShimizuTomoyasu KatoYasuhiro Fujiwara Original Article 22 February 2014 Pages: 82 - 89
Estramustine phosphate sodium in heavily pretreated patients with metastatic breast cancer: a retrospective consecutive case series Gaetano AurilioRossella GraffeoAron Goldhirsch Original Article 12 April 2014 Pages: 90 - 94
Effect of TU-100, a traditional Japanese medicine, administered after hepatic resection in patients with liver cancer: a multi-center, phase III trial (JFMC40-1001) Mitsuo ShimadaYuji MorineMasaki Kitajima Original Article 06 March 2014 Pages: 95 - 104
Development of hypertension within 2 weeks of initiation of sorafenib for advanced hepatocellular carcinoma is a predictor of efficacy Noriyuki AkutsuShigeru SasakiYasuhisa Shinomura Original Article 18 April 2014 Pages: 105 - 110
Phase II study of first-line chemotherapy with uracil-tegafur plus oral leucovorin in elderly (≥75 years) Japanese patients with metastatic colorectal cancer: SGOSG-CR0501 study Toshihiko MatsumotoTomohiro NishinaIchinosuke Hyodo Original Article 20 February 2014 Pages: 111 - 116
Usefulness of alternate-day administration of S-1 and leucovorin in a xenograft mouse model of colorectal cancer: a shorter drug-free interval leads to more efficient antitumor effects Toshihiro KomuraKoh MiuraMichiaki Unno Original Article 08 May 2014 Pages: 117 - 125
Cytokine profile in cervical mucosa of Japanese patients with cervical intraepithelial neoplasia Takashi IwataTakuma FujiiDaisuke Aoki Original Article 01 March 2014 Pages: 126 - 133
Performance of p16INK4a/Ki-67 immunocytochemistry for identifying CIN2+ in atypical squamous cells of undetermined significance and low-grade squamous intraepithelial lesion specimens: a Japanese Gynecologic Oncology Group study Takuma FujiiMiyuki SaitoDaisuke Aoki Original Article 18 April 2014 Pages: 134 - 142
Clinical features of long-term survivors of recurrent epithelial ovarian cancer Haruko IwaseToshio TakadaNobuhiro Takeshima Original Article 26 March 2014 Pages: 143 - 149
Preoperative differentiation between benign and malignant renal masses smaller than 4 cm treated with partial nephrectomy Masatomo NishikawaHideaki MiyakeMasato Fujisawa Original Article 15 February 2014 Pages: 150 - 155
Preoperative risk stratification for cancer-specific survival of patients with upper urinary tract urothelial carcinoma treated by nephroureterectomy Kazutoshi FujitaMotohide UemuraNorio Nonomura Original Article 18 April 2014 Pages: 156 - 163
External validation of existing nomograms predicting lymph node metastases in cystectomized patients Miroslav M. StojadinovicRade I. Prelevic Original Article 11 April 2014 Pages: 164 - 170
Prostate-specific antigen measured 3 months after radical prostatectomy as a new predictor of biochemical recurrence Hitoshi InoueKensaku NishimuraTsuneo Hara Original Article 21 March 2014 Pages: 171 - 175
Prostate-specific antigen density predicts extracapsular extension and increased risk of biochemical recurrence in patients with high-risk prostate cancer who underwent radical prostatectomy Takuya KoieKoji MitsuzukaYuki Tobisawa Original Article 29 April 2014 Pages: 176 - 181
A statistical study on malignant melanoma over the past 12 years in Fukui University Hospital Masato YasutaSuguru SatoTakahiro Kiyohara Original Article 15 March 2014 Pages: 182 - 187
Role of sentinel lymph node biopsy in patients with Merkel cell carcinoma: statistical analysis of 403 reported cases Yoshitsugu ShibayamaShinichi ImafukuJuichiro Nakayama Original Article 01 April 2014 Pages: 188 - 193
Combination chemotherapy of low-dose 5-fluorouracil and cisplatin for advanced extramammary Paget’s disease Yasutaka TokudaFuyuko ArakuraHisashi Uhara Original Article 02 April 2014 Pages: 194 - 197
Efficacy and safety of sublingual fentanyl orally disintegrating tablet at doses determined by titration for the treatment of breakthrough pain in Japanese cancer patients: a multicenter, randomized, placebo-controlled, double-blind phase III trial Naohito ShimoyamaIkuo GomyoMegumi Shimoyama Original Article 20 May 2014 Pages: 198 - 206